搜索





搜索





市场行情
/
股票
/
crnx
/

Crinetics Pharmaceuticals Inc

CRNX

添加自选

83.865USD

+0.135+0.16%

收盘 07-27 16:00（美东）报价延迟15分钟

8.83B总市值

亏损市盈率 TTM

Crinetics Pharmaceuticals Inc

83.865

+0.135+0.16%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

CRNX 利润表

您可以在这里找到Crinetics Pharmaceuticals Inc的年度或季度收入报告，以深入了解Crinetics Pharmaceuticals Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

营业总收入

2873.41%10.73M

--6.16M

--143.00K

158.40%1.03M

-43.59%361.00K

--0.00

-100.00%0.00

-59.62%399.00K

-76.11%640.00K

-100.00%0.00

-24.45%346.00K

125.06%988.00K

-14.44%2.68M

-34.23%709.00K

--458.00K

--439.00K

--3.13M

--1.08M

--0.00

-100.00%0.00

--0.00

-80.65%71.00K

-58.90%321.00K

-7.85%505.00K

-100.00%0.00

-16.97%367.00K

47.92%781.00K

-14.37%548.00K

-21.03%657.00K

882.22%442.00K

--528.00K

--640.00K

--832.00K

--45.00K

营业收入

2873.41%10.73M

--6.16M

--143.00K

158.40%1.03M

-43.59%361.00K

--0.00

-100.00%0.00

-59.62%399.00K

-76.11%640.00K

-100.00%0.00

-24.45%346.00K

125.06%988.00K

-14.44%2.68M

-34.23%709.00K

--458.00K

--439.00K

--3.13M

--1.08M

--0.00

-100.00%0.00

--0.00

-80.65%71.00K

-58.90%321.00K

-7.85%505.00K

-100.00%0.00

-16.97%367.00K

47.92%781.00K

-14.37%548.00K

-21.03%657.00K

882.22%442.00K

--528.00K

--640.00K

--832.00K

--45.00K

主营业务成本

--200.00K

--1.08M

----

营业费用

35.20%151.11M

47.58%139.83M

62.57%142.73M

56.46%130.14M

50.69%111.77M

51.21%94.75M

48.00%87.80M

54.09%83.18M

46.41%74.17M

29.82%62.66M

35.10%59.32M

24.14%53.98M

37.07%50.66M

50.99%48.27M

57.92%43.91M

66.68%43.48M

61.26%36.96M

46.69%31.97M

50.71%27.81M

54.11%26.09M

28.37%22.92M

40.27%21.79M

17.27%18.45M

26.86%16.93M

71.48%17.85M

52.12%15.54M

82.57%15.73M

110.49%13.35M

74.45%10.41M

237.14%10.21M

185.93%8.62M

156.16%6.34M

124.87%5.97M

--3.03M

--3.01M

--2.48M

--2.65M

研发费用

31.27%100.08M

27.77%85.05M

46.13%90.46M

37.63%80.30M

42.93%76.24M

46.04%66.57M

41.21%61.91M

43.56%58.34M

38.66%53.34M

23.22%45.58M

37.05%43.84M

23.17%40.64M

36.16%38.47M

50.35%36.99M

48.23%31.99M

61.05%32.99M

60.67%28.25M

46.19%24.60M

57.53%21.58M

62.50%20.49M

26.85%17.58M

38.60%16.83M

15.87%13.70M

22.58%12.61M

91.07%13.86M

58.71%12.14M

71.70%11.82M

96.96%10.29M

53.71%7.25M

198.63%7.65M

172.93%6.89M

150.70%5.22M

128.57%4.72M

--2.56M

--2.52M

--2.08M

--2.06M

折旧摊销及损耗

25.41%1.16M

26.14%994.00K

31.43%1.01M

27.36%959.00K

95.15%925.00K

200.76%788.00K

182.05%770.00K

168.93%753.00K

67.49%474.00K

-6.43%262.00K

10.08%273.00K

30.23%280.00K

17.92%283.00K

19.15%280.00K

6.44%248.00K

-6.52%215.00K

7.14%240.00K

4.44%235.00K

-4.51%233.00K

-5.74%230.00K

-4.68%224.00K

-1.75%225.00K

7.02%244.00K

6.09%244.00K

17.50%235.00K

10.10%229.00K

64.03%228.00K

202.63%230.00K

316.67%200.00K

333.33%208.00K

189.58%139.00K

204.00%76.00K

77.78%48.00K

--48.00K

--25.00K

--27.00K

营业利润

-26.01%-140.38M

-41.08%-133.67M

-62.40%-142.59M

-55.96%-129.11M

-51.51%-111.41M

-51.21%-94.75M

-48.87%-87.80M

-56.21%-82.78M

-53.26%-73.53M

-31.76%-62.66M

-35.72%-58.98M

-23.12%-52.99M

-41.83%-47.98M

-53.96%-47.56M

-56.27%-43.45M

-64.99%-43.05M

-47.60%-33.83M

-41.75%-30.89M

-50.71%-27.81M

-54.11%-26.09M

-28.88%-22.92M

-43.23%-21.79M

-21.16%-18.45M

-26.86%-16.93M

-77.04%-17.78M

-61.32%-15.21M

-88.71%-15.23M

-134.82%-13.35M

-81.76%-10.04M

-277.09%-9.43M

-239.93%-8.07M

-245.89%-5.68M

-111.81%-5.53M

---2.50M

---2.37M

---1.64M

---2.61M

净非营业利息收入（费用）

利息收入

-14.63%12.66M

-22.36%11.16M

13.97%12.54M

53.93%13.46M

102.65%14.83M

113.75%14.37M

328.42%11.01M

314.86%8.74M

259.18%7.32M

253.05%6.72M

71.27%2.57M

192.64%2.11M

955.96%2.04M

2280.00%1.90M

6150.00%1.50M

3030.43%720.00K

543.33%193.00K

50.94%80.00K

-80.33%24.00K

-91.15%23.00K

-94.60%30.00K

-91.91%53.00K

-85.39%122.00K

-72.92%260.00K

-44.95%556.00K

-34.43%655.00K

56.37%835.00K

535.76%960.00K

1478.13%1.01M

16550.00%999.00K

8800.00%534.00K

2057.14%151.00K

814.29%64.00K

--6.00K

--7.00K

利息费用

----

-100.00%0.00

--1.00K

--2.00K

--3.00K

--2.00K

出售证券收益

----

178.05%32.00K

100.57%34.00K

-238.18%-186.00K

-17.79%23.10M

-10.81%-41.00K

-7400.00%-6.00M

-423.53%-55.00K

401528.57%28.10M

21.28%-37.00K

-175.86%-80.00K

170.83%17.00K

---7.00K

---47.00K

---29.00K

---24.00K

----

特殊收入（费用）

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

----

--569.00K

--0.00

--31.00K

----

其他非经营性收入（费用）

35.47%-131.00K

42.66%-125.00K

28.99%-49.00K

142.55%20.00K

-212.31%-203.00K

99.05%-218.00K

-475.00%-69.00K

-100.80%-47.00K

---65.00K

17.66%-23.06M

-118.18%-12.00K

591000.00%5.91M

----

-133471.43%-28.01M

414.29%66.00K

---1.00K

----

-78.35%21.00K

-333.33%-21.00K

----

108.21%11.00K

870.00%97.00K

125.00%9.00K

523.81%178.00K

-844.44%-134.00K

115.87%10.00K

30.77%-36.00K

-16.67%-42.00K

1000.00%18.00K

-152.00%-63.00K

-333.33%-52.00K

-300.00%-36.00K

0.00%-2.00K

---25.00K

---12.00K

---9.00K

---2.00K

税前利润

-32.11%-127.84M

-52.16%-122.64M

-69.33%-130.09M

-56.15%-115.64M

-45.61%-96.77M

-44.19%-80.59M

-36.07%-76.83M

-45.27%-74.06M

-44.49%-66.46M

-24.24%-55.90M

-34.67%-56.46M

-20.30%-50.98M

-36.82%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-46.79%-33.62M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

所得税

----

--180.00K

----

--0.00

----

--0.00

----

除税后的权益收益

----

--0.00

----

100.00%0.00

--0.00

---470.00K

---4.20M

---997.00K

--0.00

100.00%0.00

--0.00

---1.01M

----

除税后利润

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-45.61%-96.77M

-44.19%-80.59M

-36.07%-76.83M

-45.27%-74.06M

-44.49%-66.46M

-24.24%-55.90M

-34.67%-56.46M

-20.30%-50.98M

-36.82%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-46.79%-33.62M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

持续经营利润

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

反常净利润

----

--0.00

----

归属于母公司的净利润

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

归属于普通股东的净利润

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

基本每股收益

-18.15%-1.23

-46.79%-1.29

-43.94%-1.38

-31.54%-1.23

-12.27%-1.04

1.52%-0.88

5.16%-0.96

0.21%-0.94

-8.52%-0.93

-6.94%-0.89

-29.72%-1.01

-16.42%-0.94

-17.56%-0.85

-22.89%-0.84

-7.25%-0.78

-14.58%-0.81

-4.62%-0.73

-3.55%-0.68

-30.52%-0.73

-34.11%-0.70

2.14%-0.69

-9.34%-0.66

6.55%-0.56

-2.08%-0.53

-89.45%-0.71

-74.17%-0.60

-88.81%-0.60

-121.92%-0.51

-50.72%-0.37

-200.91%-0.34

-191.70%-0.32

-209.52%-0.23

-109.67%-0.25

---0.11

---0.07

---0.12

稀释每股收益

-18.15%-1.23

-46.79%-1.29

-43.94%-1.38

-31.54%-1.23

-12.27%-1.04

1.52%-0.88

5.16%-0.96

0.21%-0.94

-8.52%-0.93

-6.94%-0.89

-29.72%-1.01

-16.42%-0.94

-17.56%-0.85

-22.89%-0.84

-7.25%-0.78

-14.58%-0.81

-4.62%-0.73

-3.55%-0.68

-30.52%-0.73

-34.11%-0.70

2.14%-0.69

-9.34%-0.66

6.55%-0.56

-2.08%-0.53

-89.45%-0.71

-74.17%-0.60

-88.81%-0.60

-121.92%-0.51

-50.72%-0.37

-200.91%-0.34

-191.70%-0.32

-209.52%-0.23

-109.67%-0.25

---0.11

---0.07

---0.12

每股派息

--0.00

-100.00%0.00

--0.00

--0.42

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Crinetics Pharmaceuticals Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 CRNX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Crinetics Pharmaceuticals Inc 财年末的营收是多少？



Crinetics Pharmaceuticals Inc 2025 财年营收为 7.70M，高于上一财年的1.04M。

Crinetics Pharmaceuticals Inc 最近一个季度的营收是多少？



Crinetics Pharmaceuticals Inc 最近一个季度的营收为 10.73M，同比增长 2873.41%。

Crinetics Pharmaceuticals Inc 全年的净利润是多少？



Crinetics Pharmaceuticals Inc 2025 财年净利润为 -465.32M。

Crinetics Pharmaceuticals Inc 上一季度的净利润是多少？



Crinetics Pharmaceuticals Inc 最近一个季度的净利润为 -127.84M。

Crinetics Pharmaceuticals Inc 年度营业利润是多少？



Crinetics Pharmaceuticals Inc 2025 财年的营业利润为 -516.77M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。